Penumbra Inc
F:0P8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Penumbra Inc
F:0P8
|
US |
|
Pharma Equity Group A/S
CSE:PEG
|
DK |
|
Maxim Power Corp
F:MP9
|
CA |
|
Adventus Holdings Ltd
SGX:5EF
|
SG |
Intrinsic Value
Is 0P8 undervalued or overvalued?
See the intrinsic value estimate for 
Penumbra Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Penumbra Does
Penumbra makes medical devices that doctors use to treat blood clots and other vascular problems. Its products include catheter-based systems for removing clots, embolization devices used to block blood flow in abnormal vessels, and tools for navigating and treating vessels in the brain and body. The company sells mainly to hospitals, outpatient procedure centers, and the physicians who perform these interventions.
- Headquarters
- United States of America US
- Employees
- 4 700
- IPO date
- Sep 18, 2015
Penumbra has no economic moat
Hospitals and specialist physicians can choose among competing clot-removal and neurovascular devices, and Penumbra says decisions depend on safety, effectiveness and price. Its name and manufacturing scale do not appear to stop established rivals from offering alternatives or discounts.
Read the full moat analysis
Revenue & Expenses Breakdown
Penumbra Inc
Earnings Waterfall
Penumbra Inc
The intrinsic value for Penumbra Inc (0P8) under the Base Case is hidden EUR.
Compared with the current market price of 284.4 EUR, the stock appears hidden.